Cross-environment redirection

File for Quick & Easy Patent Protection with PowerPatent.

The Z124 patent solves the following problem:

This relates generally to the field of mobile environments Computing, and especially to support many user environment through the use of multiple operating systems on a single mobile computing device.

Our analysis of this patent is as follows:

Z124’s patent US 8683496 B2 deals with Cross-environment redirection.
Cross-around providing support and companionship user to provide a seamless computing experience in a multi-operating system environment Computing. The multi-operating system computing environments may include a mobile operating system and a desktop operating system running simultaneously and independently on a mobile device Computing. Full user interaction support given for redirected and / or application showed rendered using a long graphics context. A high input queue handles input events from the virtual input devices for remote application shown. Distance showed maps application to another space motion in the input queue. The mobile computing device may be a smartphone running the Android mobile operating system and a complete desktop Linux distribution on a modified Android kernel.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Methods of using BTL-II proteins

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time for Utility, Provisional or Design Patent Creation with PowerPatent software and services.

The Immunex Corporation patent solves the following problem:

Modulation of an immune or inflammatory response can be a valuable tool to control various types of diseases including autoimmune diseases, diseases characterized by abnormal inflammation and / or immune response, and infections . In treating diseases characterized by abnormal inflammation and / or immune responses, such as inflammatory bowel disease and autoimmune or inflammatory diseases, modulation of an immune response is desirable. In other situations, for example when the vaccine to a patient to give immunity to an infectious disease, stimulation of an immune response is desirable. In the case of vaccines, adjuvants on an immune response to a coadministered antigen can be valuable in providing long term protection against the disease. Particularly lacking in the art is the adjuvants capable of stimulating a mucosal immune response. A mucosal immune response, as opposed to a systemic immune response, is valuable because it attacks an infection with a very common point of entry, that is, to a mucosal surface. The present invention addresses these needs in the art by providing therapeutic agents for the diagnosis and treatment of diseases characterized by inadequate and / or abnormal inflammation and / or immune response and therapeutic agents that act as adjuvants to stimulate an immune response, particularly a mucosal immune response.

Our analysis of this patent is as follows:

Immunex Corporation’s patent US 8674078 B2 deals with Methods of using BTL-II proteins.
invention provides isolated BTL-II protein, nucleic acid, antibody, enemies, and agonists and methods of making and using the same. Diagnostic, screening, and therapeutic methods of using the compositions of the invention given. For example, the composition of the invention can be used for diagnosis and treatment of inflammatory intestinal diseases and for the development of a mucosal immune response to an antigen.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Endpoint-hosted hypervisor management

Use PowerPatent’s Online Patent Filing Service to get quick patent protection for your great idea.

The International Business Machines Corporation patent solves the following problem:

The invention relates to the electronic network. Particularly, the invention relates to the endpoint host hypervisor management.

Our analysis of this patent is as follows:

International Business Machines Corporation’s patent US 8677358 B2 deals with Endpoint-hosted hypervisor management.
A client hypervisor consists of a virtual agent that runs out of a system of the OS, and that allows to manage devices independent of the OS and the user. The virtual agents tied to one device and not to a specific time of the OS. Such client hypervisors expose new functionality to ease system management. Some of these capabilities from endurance and privileges without the OS. In some embodiments of the invention, this new management functionality to spread the rule of the device with new virtualization concepts, such as the number of VMs per system, VM instead, snapshot / rollback, etc.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.